Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

Clinical trial NCT05383872 · COMPLETED

Trial details

NCT number: NCT05383872
Sponsor: InSightec
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma Glioma Liquid Biopsy

Start date: 2022-08-08
Primary completion: 2025-02-21
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.